News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Lymphoma’ clear

  • "Twinning" U.S.-based and Rwandan physicians in a team approach has shown to improve lymphoma outcomes in children in a country lacking any specialists in children's cancers.

Tags: BasicResearch, ChildhoodCancer, Lymphoma

  • Dana-Farber researchers found levels of galectin-1, an immunity-related protein, could be the basis of a test, and potentially a targeted treatment for Hodgkin lymphoma.

Tags: TargetedTherapy, Lymphoma

  • Castle Connolly Medical Ltd. will recognize George Canellos, MD, an internationally renowned hematology/oncology expert at Dana Farber Cancer Institute, for his work in the treatment of advanced Hodgkin's disease and non-Hodgkin lymphoma.

Tags: Honors, Lymphoma

  • A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.

Tags: chemotherapy, ChildhoodCancer, Lymphoma

  • Dana-Farber researchers and their colleagues report a toxin linked to a targeted monoclonal antibody has shown antitumor activity in patients with non-Hodgkin lymphomas who were no longer responding to treatment.

Tags: Lymphoma

  • Dana-Farber researchers identify a specific mutation that switches on Waldenström's Macroglobulinemia in one-third of patients, and a drug that targets the mutation — which could lead to better treatments for those patients.

Tags: Genetics, Lymphoma

  • Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.

Tags: Lymphoma, Immunotherapy

  • Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

Tags: EGFR, Genomics, LungCancer, OvarianCancer, ProstateCancer, Lymphoma, Immunotherapy

  • Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.

Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma

  • Dana-Farber researchers have found a genetic signature in tumors to help them determine if diffuse large B cell lymphoma patients will benefit more from traditional therapies or targeted therapies.

Tags: BasicResearch, Lymphoma

Showing 1-10 of 16 items